» Articles » PMID: 37654822

Nano Eggshell-titanium-dioxide Biocomposite in Occluding Opened Dentine Tubules

Overview
Journal Bioinformation
Specialty Biology
Date 2023 Sep 1
PMID 37654822
Authors
Affiliations
Soon will be listed here.
Abstract

It is of interest to synthesize Nano eggshell-titanium-dioxide (EB@TiO2) biocomposite and to evaluate its effectiveness in occluding opened dentine tubules. EB@TiO2 was synthesized and characterized using X-ray diffraction (XRD), and Transmission Electron Microscope (TEM). Sixteen simulated bovine dentine discs were prepared and randomly assigned into four groups according to the following treatment (n = 4): Group 1: No treatment; Group 2: eggshell powder; Group 3: EB@TiO2; and Group 4: GIC mousse. These were then, agitated in a solution of 1g powder and 40mL water for 3hours. Thereafter, each dentine discs from the respective groups were post-treated for 5 min with 2wt% citric acid to test their acid resistant characteristics. Scanning Electron Microscope (SEM) was used to observe the effectiveness of occluded dentine pre-treatment and post-treatment. The cytotoxicity of the synthesized EB@TiO2 was tested using NIH 3T3 assay. ANOVA was used to evaluate the mean values of the occluded area ratio and the data of MTS assay. This was followed by a multi-comparison test with Bonferroni correction (α = .05). The XRD confirmed that EB@TiO2 was successfully modified through ball-milling. The TEM revealed the presence of both spherical and irregular particle shape powders. The SEM result showed that EB@TiO2 could effectively occlude open dentine tubules. Equally, the result demonstrated that EB@TiO2 exhibited the highest acid resistant stability post-treatment. NIH 3T3 assay identified that EB@TiO2 had little effect on the NIH 3T3 cell line even at the highest concentration of 100µg/ml. This study suggests that the application of EB@TiO2 effectively occluded dentine tubules and the occlusion showed a high acid resistant stability.

References
1.
Pandit N, Gupta R, Bansal A . Comparative evaluation of two commercially available desensitizing agents for the treatment of dentinal hypersensitivity. Indian J Dent Res. 2013; 23(6):778-83. DOI: 10.4103/0970-9290.111259. View

2.
Yang Z, Wang F, Lu K, Li Y, Zhou Z . Arginine-containing desensitizing toothpaste for the treatment of dentin hypersensitivity: a meta-analysis. Clin Cosmet Investig Dent. 2016; 8:1-14. PMC: 4708190. DOI: 10.2147/CCIDE.S95660. View

3.
Schiff T, Delgado E, Zhang Y, Cummins D, DeVizio W, Mateo L . Clinical evaluation of the efficacy of an in-office desensitizing paste containing 8% arginine and calcium carbonate in providing instant and lasting relief of dentin hypersensitivity. Am J Dent. 2009; 22 Spec No A:8A-15A. View

4.
Yu J, Yang H, Li K, Lei J, Zhou L, Huang C . A novel application of nanohydroxyapatite/mesoporous silica biocomposite on treating dentin hypersensitivity: An in vitro study. J Dent. 2016; 50:21-9. DOI: 10.1016/j.jdent.2016.04.005. View

5.
Yazicioglu O, Ulukapi H . The investigation of non-invasive techniques for treating early approximal carious lesions: an in vivo study. Int Dent J. 2014; 64(1):1-11. PMC: 9375040. DOI: 10.1111/idj.12056. View